In a study analyzing data from 660 patients who underwent ICC hepatectomy, researchers developed the LabScore score by combining platelet count, CA19-9, albumin, and neutrophil to lymphocyte ratio (NLR) to predict ICC prognosis. This evidence concerns the gene ALB and intrahepatic cholangiocarcinoma.